underweight patients could have affected the outcome results (especially overall survival) of normal weight ones, leading to incorrect conclusions.
The second weak point is the possible confounding effect of patients' characteristics, because some of the papers used in the meta-analysis showed significant differences among BMI groups (obese, overweight, normal weight, underweight) in terms of histology, pathological T stage, and neoadjuvant therapy. Kayani et al. included this facet in the limitations section, but they presented the results of the comparisons anyway.
In conclusion, we think that the comparison between obese subjects and normal weight ones could have been a better choice. In addition, the lack of homogeneity-in terms of possible confounders-in BMI groups should have been addressed as the reason for interrupting the meta-analysis and for concluding that literature data were not useful for the purpose of the paper.
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